Loading...
XHEL
OPTOMED
Market cap84mUSD
Dec 03, Last price  
3.64EUR
1D
-1.09%
1Q
-2.93%
IPO
-41.29%
Name

Optomed Oyj

Chart & Performance

D1W1MN
P/E
P/S
4.76
EPS
Div Yield, %
Shrs. gr., 5y
15.89%
Rev. gr., 5y
0.08%
Revenues
15m
-0.40%
6,609,0006,899,00014,463,00014,977,00013,011,00014,850,00014,660,00015,100,00015,040,000
Net income
-5m
L+22.72%
-2,758,000-2,887,000-1,268,000-2,875,000-3,177,000-4,249,000-5,472,000-4,441,000-5,450,000
CFO
-2m
L+159.51%
-810,000-766,000-76,000161,000-2,801,000-2,940,000-2,370,000-615,000-1,596,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Optomed Oyj, a medical technology company, manufactures and sells handheld fundus cameras and screening software in Finland, China, and internationally. The company operates through two segments, Devices and Software segments. The company develops, manufactures, and sells fundus camera products, which are used by ophthalmologists, pediatricians, endocrinologists, neurologists, and primary care professionals. It offers camera products under the Optomed Smartscope Pro, Optomed Aurora, Optomed Polaris, and Optomed Halo brands, as well as OEM cameras, including Pictor Plus, Pictor Prestige, Visuscout 100, Fundus Module 300, and Signal brand names. The company also provides Avenue Eye Screen, a workflow management software for screening and monitoring of eye diseases, such as diabetic retinopathy; Avenue Archive, an application software for displaying, archiving, and transmitting healthcare information; Avenue Telemedicine, a telemedicine solution for remote image analysis; Avenue AI, an automated diabetic retinopathy screening service; and Avenue Sync, a software solution for integrating fundus camera to the hospital image archive and worklist server. In addition, it offers Avenue Cancer Screen, a screening process management software for breast, cervical, and colorectal cancer; Optomed RIS, a software solution for healthcare imaging units for enhancing the diagnostic process and treatment decisions; Sectra PACS, a modular system optimized for use by high production healthcare providers; Optomed Service Portal, a support function for healthcare units that order and produce imaging services; Facad, a tracing software for visible light imaging and cephalometric measurements; and Sectra PACS Pathology, a digital pathology solution, which allows scanned glass slides to be distributed and diagnosed. Further, the company provides professional IT consulting services for government institutions. It sells its products and solutions through OEMs, distributors, and direct sales. The company's customers include hospitals, eye clinics, and optician chains and stores. The company was incorporated in 2004 and is headquartered in Oulu, Finland.
IPO date
Dec 09, 2019
Employees
115
Domiciled in
FI
Incorporated in
FI

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT